HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Regulation of transglutaminase-mediated hepatic cell death in alcoholic steatohepatitis and non-alcoholic steatohepatitis.

AbstractBACKGROUND AND AIM:
Transglutaminase 2 (TG2), catalyzing crosslinking between lysine and glutamine residues, is involved in many liver diseases. We previously reported that TG2, induced in the nucleus of ethanol- or free fatty acids (FFAs)-treated hepatic cells, crosslinks and inactivates a transcription factor Sp1, leading to reduced expression of c-Met and thereby caspase independent hepatic apoptosis in culture systems, animal models, and both alcoholic steatohepatitis (ASH) and non-alcoholic steatohepatitis (NASH) patients. FFAs increase endoplasmic reticulum (ER) stress, NFkB activation and nuclear TG2 (nTG2) through pancreatic ER kinase (PERK)-dependent pathway, whereas ethanol induces nTG2 via retinoid signaling. However, the molecular mechanism by which ethanol/FFAs induce nuclear localization of TG2 has been unclear.
METHOD:
A similar nTG2-mediated cell death is induced in acyclic retinoid (ACR)-treated hepatocellular carcinoma. Using cultured cells, we investigated how to control this novel apoptotic pathway by regulating nuclear localization of TG2.
RESULTS:
TG2 is composed of N-terminal b-sandwich, catalytic core, b-barrel 1, and C-terminal b-barrel 2 domains. In a previous work, we identified a 14 amino acid nuclear localization signal (NLS) within the b-barrel 1 domain and a putative leucine-rich nuclear export signal (NES) at position 657 to 664 (LHMGLHKL) near the C-terminus in the b-barrel 2 domain, and found that ACR downregulated exportin-1 levels, thereby accumulation of TG2 in the nucleus. Here, we found that both ethanol and FFAs provoked generation of truncated short form of TG2 (TG2-S) defects in the putative NES at least in part through alternative splicing, thereby causing accumulation of TG2-S in the nucleus.
CONCLUSION:
The generation of TG2-S in ethanol or FFAs-treated hepatic cells is a novel therapeutic target for prevention of hepatic cell death associated with ASH/NASH.
AuthorsSoichi Kojima, Ting-Fang Kuo, Hideki Tatsukawa
JournalJournal of gastroenterology and hepatology (J Gastroenterol Hepatol) Vol. 27 Suppl 2 Pg. 52-7 (Mar 2012) ISSN: 1440-1746 [Electronic] Australia
PMID22320917 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2012 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.
Chemical References
  • Fatty Acids, Nonesterified
  • Karyopherins
  • Protein Sorting Signals
  • Receptors, Cytoplasmic and Nuclear
  • exportin 1 protein
  • Ethanol
  • Protein Glutamine gamma Glutamyltransferase 2
  • Transglutaminases
  • GTP-Binding Proteins
Topics
  • Active Transport, Cell Nucleus
  • Alternative Splicing
  • Cell Death
  • Cell Nucleus (drug effects, enzymology, pathology)
  • Ethanol (toxicity)
  • Fatty Acids, Nonesterified (toxicity)
  • Fatty Liver (enzymology, pathology)
  • Fatty Liver, Alcoholic (enzymology, pathology)
  • GTP-Binding Proteins
  • Hep G2 Cells
  • Humans
  • Karyopherins (metabolism)
  • Liver (drug effects, enzymology, pathology)
  • Non-alcoholic Fatty Liver Disease
  • Protein Glutamine gamma Glutamyltransferase 2
  • Protein Sorting Signals
  • Receptors, Cytoplasmic and Nuclear (metabolism)
  • Signal Transduction
  • Transglutaminases (chemistry, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: